UniProtKB/Swiss-Prot P06858: Variant p.Ala288Thr

• Variant information
• Sequence information
• Literature citations
• All

Variant information

Variant position: 288 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: LP/P [Disclaimer: Variants classification is intended for research purposes only, not for clinical and diagnostic use. The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant.] The variants are classified into three categories: LP/P, LB/B and US.

• LP/P: likely pathogenic or pathogenic.
• LB/B: likely benign or benign.
• US: uncertain significance

Residue change: From Alanine (A) to Threonine (T) at position 288 (A288T, p.Ala288Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: Change from small size and hydrophobic (A) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

• Lowest score: -4 (low probability of substitution).
• Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description: In HLPP1; the LPL mass level is approximately 67% of the normal; the activity is 32% of the nornal. Any additional useful information about the variant.
Other resources: Links to websites of interest for the variant.

• Variant rs1800011 [ dbSNP | Ensembl ]

Sequence information

Variant position: 288 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 475 The length of the canonical sequence.
Location on the sequence: HERSIHLFIDSLLNEENPSK A YRCSSKEAFEKGLCLSCRKN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

• Type: the type of sequence feature.
• Positions: endpoints of the sequence feature.
• Description: contains additional information about the feature.

Type	Positions	Description
Chain	28 – 475	Lipoprotein lipase
Active site	268 – 268	Charge relay system
Mutagenesis	268 – 268	H -> G. Loss of enzyme activity with triolein and tributyrin.
Mutagenesis	268 – 268	H -> Q. Loss of enzyme activity with triolein and tributyrin.
Beta strand	287 – 290

Literature citations

High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform.
Ma Y.; Ooi T.C.; Liu M.-S.; Zhang H.; McPherson R.; Edwards A.L.; Forsythe I.J.; Frohlich J.; Brunzell J.D.; Hayden M.R.;
J. Lipid Res. 35:1066-1075(1994)
Cited for: VARIANTS HLPP1 CYS-199; ARG-279 AND THR-288; CHARACTERIZATION OF VARIANTS HLPP1 ARG-279 AND THR-288; Common genetic variants of lipoprotein lipase and apolipoproteins AI-CIII that relate to coronary artery disease: a study in Chinese and European subjects.
Zhang Q.; Liu Y.; Liu B.W.; Fan P.; Cavanna J.; Galton D.J.;
Mol. Genet. Metab. 64:177-183(1998)
Cited for: VARIANT HLPP1 THR-288; VARIANTS ASN-36 AND SER-318; INVOLVEMENT IN FCHL3; Mutations in Japanese subjects with primary hyperlipidemia -- results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996.
Maruyama T.; Yamashita S.; Matsuzawa Y.; Bujo H.; Takahashi K.; Saito Y.; Ishibashi S.; Ohashi K.; Shionoiri F.; Gotoda T.; Yamada N.; Kita T.;
J. Atheroscler. Thromb. 11:131-145(2004)
Cited for: VARIANTS HLPP1 SER-70; ARG-132; VAL-181; GLU-215; THR-221; ARG-225; ALA-227; GLU-231; CYS-270; HIS-270; THR-288; LEU-297; ARG-305; PHE-330 AND THR-361;